Search Results - Radek Fedr
- Showing 1 - 8 results of 8
-
1
-
2
Nonhistone Proteins HMGB1 and HMGB2 Differentially Modulate the Response of Human Embryonic Stem Cells and the Progenitor Cells to the Anticancer Drug Etoposide by Alireza Jian Bagherpoor, Martin Kučírek, Radek Fedr, Soodabeh Abbasi Sani, Michal Štros
Published in Biomolecules (2020-10-01)Get full text
Article -
3
BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors by Hana Paculová, Juraj Kramara, Šárka Šimečková, Radek Fedr, Karel Souček, Ondřej Hylse, Kamil Paruch, Marek Svoboda, Martin Mistrík, Jiří Kohoutek
Published in Tumor Biology (2017-10-01)Get full text
Article -
4
Orthotopic model for the analysis of melanoma circulating tumor cells by Markéta Pícková, Zuzana Kahounová, Tomasz Radaszkiewicz, Jiřina Procházková, Radek Fedr, Michaela Nosková, Katarzyna Anna Radaszkiewicz, Petra Ovesná, Vítězslav Bryja, Karel Souček
Published in Scientific Reports (2024-04-01)Get full text
Article -
5
Single‐cell protein profiling defines cell populations associated with triple‐negative breast cancer aggressiveness by Barbora Kvokačková, Radek Fedr, Daniela Kužílková, Jan Stuchlý, Adéla Vávrová, Jiří Navrátil, Pavel Fabian, Róbert Ondruššek, Petra Ovesná, Ján Remšík, Jan Bouchal, Tomáš Kalina, Karel Souček
Published in Molecular Oncology (2023-06-01)Get full text
Article -
6
Single-cell profiling of surface glycosphingolipids opens a new dimension for deconvolution of breast cancer intratumoral heterogeneity and phenotypic plasticity by Jiřina Procházková, Radek Fedr, Barbora Hradilová, Barbora Kvokačková, Josef Slavík, Ondrej Kováč, Miroslav Machala, Pavel Fabian, Jiří Navrátil, Simona Kráčalíková, Monika Levková, Petra Ovesná, Jan Bouchal, Karel Souček
Published in Journal of Lipid Research (2024-09-01)Get full text
Article -
7
Incorporation of Low Concentrations of Gold Nanoparticles: Complex Effects on Radiation Response and Fate of Cancer Cells by Lucie Dobešová, Theresa Gier, Olga Kopečná, Eva Pagáčová, Tomáš Vičar, Felix Bestvater, Jiří Toufar, Alena Bačíková, Pavel Kopel, Radek Fedr, Georg Hildenbrand, Iva Falková, Martin Falk, Michael Hausmann
Published in Pharmaceutics (2022-01-01)Get full text
Article -
8
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe by Stanislav Drápela, Prashant Khirsariya, Wytske M. vanWeerden, Radek Fedr, Tereza Suchánková, Diana Búzová, Jan Červený, Aleš Hampl, Martin Puhr, William R. Watson, Zoran Culig, Lumír Krejčí, Kamil Paruch, Karel Souček
Published in Molecular Oncology (2020-10-01)Get full text
Article
